Vitamin A (Retinol)
Essential, and the One to Watch the Ceiling On
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
0 human trials, about 4 studies, Teratology literature + WHO/EFSA/IOM reviews. The written rationale for this grade is still being prepared.
- FDA
- Essential nutrient with an RDA and a strict tolerable upper limit; synthetic retinoids are prescription teratogens
- WADA
- Not prohibited
Reference only. Not medical advice.
What can go wrong
This is a two-sided nutrient, and the safety line is the form and the amount. Preformed vitamin A (retinol and retinyl esters) above the 3,000 mcg RAE tolerable upper limit is associated with birth defects, and the sensitive window is earliest, in roughly the first 60 days after conception. The forms that can push intake high are concentrated ones: high-dose vitamin A supplements, cod liver oil, and liver and liver products, which can carry very large amounts of retinol, along with non-pregnancy multivitamins such as some older-adult formulas that contain preformed vitamin A. Beta-carotene does not carry this teratogenic risk. Separately, the prescription retinoid drugs derived from vitamin A, including isotretinoin (Accutane) and oral acitretin (Soriatane), are among the most powerful known human teratogens, are strictly contraindicated in pregnancy, and carry FDA boxed warnings and pregnancy-prevention programs; topical retinoids are generally avoided in pregnancy as a precaution. Because this involves both a nutrient with a hard ceiling and drugs with severe fetal risk, any question about vitamin A intake, prenatal choice, or acne or skin medication before or during pregnancy belongs with your obstetric provider or pharmacist, who can review your specific supplements and medications. This entry does not provide dosing.
Vitamin A is essential for fetal eye, organ, and immune development, and pregnancy raises the RDA modestly to 770 mcg RAE. It is also the textbook nutrient where the form and the dose decide everything: high intakes of preformed vitamin A, meaning retinol and retinyl esters from animal foods, supplements, and synthetic sources, are teratogenic and associated with birth defects of the skull, face, heart, brain, and nervous system, with the most sensitive window in roughly the first 60 days after conception. Beta-carotene, the plant-derived form in carrots, sweet potato, and leafy greens, is converted to vitamin A only as the body needs it and is not associated with this toxicity. Authorities set a tolerable upper limit of 3,000 mcg RAE per day for preformed vitamin A specifically because of teratogenicity. The prescription retinoid drugs derived from vitamin A, such as isotretinoin, sit in a category of their own as among the most powerful known human teratogens.
A nutrient pregnancy genuinely needs, and the clearest example of a vitamin where too much, in the wrong form, causes serious birth defects.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
What people get wrong
Often saidVitamin A is dangerous in pregnancy and should be avoided.
ActuallyVitamin A is essential, and the pregnancy RDA of 770 mcg RAE is both safe and necessary for fetal eye, organ, and immune development (NIH Office of Dietary Supplements). The concern is specifically excess preformed vitamin A above the 3,000 mcg RAE upper limit; ordinary dietary intake and a pregnancy-appropriate prenatal are not the problem.
Often saidAll forms of vitamin A carry the same birth-defect risk.
ActuallyThey do not. Preformed vitamin A (retinol, retinyl palmitate) is the form linked to birth defects. Beta-carotene from fruits and vegetables is converted to vitamin A only as needed and, per NIH ODS and EFSA, is not known to be teratogenic, which is why it is the preferred supplemental form in pregnancy.
Often saidIf a little vitamin A prevents deficiency, more must be better for the baby.
ActuallyFor preformed vitamin A the opposite risk applies above the ceiling. WHO does not recommend routine vitamin A supplementation in pregnancy and reserves it for populations with severe deficiency, because high-dose supplementation shows no consistent maternal or infant mortality benefit while excess preformed retinol carries teratogenic risk.
Often saidBeta-carotene is harmless in any amount for everyone.
ActuallyBeta-carotene is not teratogenic, but high-dose beta-carotene supplements were associated with increased lung cancer in smokers in the ATBC and CARET trials, so smokers are advised to avoid beta-carotene supplements. Dietary beta-carotene from food is not implicated.
Who profits, and who pushes back
World Health Organization
Daily doses up to 10,000 IU (about 3,000 mcg retinol) are probably safe, and supplementation is beneficial in deficient populations; but high-dose preformed vitamin A in the first 60 days is teratogenic and should be avoided.
EFSA & IOM (Food and Nutrition Board)
The tolerable upper limit for preformed vitamin A is retained at 3,000 mcg RE per day for adults including women of child-bearing age, with teratogenicity selected as the critical effect on which the limit is based.
Teratology research literature
Intakes below 10,000 IU per day have not been associated with birth defects, but intakes above that are not recommended for well-nourished pregnant women; synthetic retinoids are potent teratogens and are contraindicated.
Prenatal formulation guidance
Pregnancy-appropriate prenatals supply vitamin A largely or entirely as beta-carotene to deliver the nutrient without the teratogenic risk of high preformed retinol.
Where the research comes from
Most of the published research on this comes from one place. 60% of it is from Excess-risk regions. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| Excess-risk regions | 60% |
| Deficiency-risk regions | 40% |
Research published from: Global.
How we got here
Vitamin A was among the earliest nutrients shown to be both essential and, in excess, harmful to the developing fetus. Its deficiency has been a leading cause of childhood blindness across South and Southeast Asia, sub-Saharan Africa, and parts of Latin America, and night blindness in pregnancy was described in these regions long before the vitamin was named, which is why WHO supplementation programs are anchored there. Laboratory work in the mid-twentieth century showed that excess vitamin A produced malformations in animal offspring. Human case reports and then the case-control epidemiology of Rothman and colleagues, published in 1995, established that high doses of preformed vitamin A were associated with a recognizable pattern of birth defects in people. This paralleled the striking teratogenicity of the synthetic retinoid isotretinoin, introduced for severe acne in 1982 and quickly found to cause severe malformations. Those findings led WHO, the US Institute of Medicine, and later EFSA to set upper limits anchored to teratogenicity, and prompted prenatal formulations to lean toward beta-carotene.
- pre-1900Night blindness and childhood blindness from vitamin A deficiency documented across South Asia, Southeast Asia, and sub-Saharan Africa, long before the vitamin was isolated
- 1930s-1960sAnimal studies show that excess vitamin A causes malformations in offspring, establishing its teratogenic potential
- 1982Isotretinoin (Accutane) approved for severe acne; its severe human teratogenicity becomes a defining caution
- 1995Rothman and colleagues publish in the New England Journal of Medicine that high supplemental preformed vitamin A is associated with cranial neural crest defects, prevalence ratio 4.8 above 10,000 IU/day
- 2001US Institute of Medicine sets the 3,000 mcg RAE/day tolerable upper limit for preformed vitamin A on teratogenicity grounds
- 2006FDA launches the iPLEDGE risk management program for isotretinoin to prevent fetal exposure
- 2011WHO guideline advises against routine vitamin A supplementation in pregnancy, reserving it for areas where deficiency is a severe public health problem
- 2024EFSA reaffirms the 3,000 mcg RE/day upper limit for preformed vitamin A after systematic review, with teratogenicity as the critical effect
At a glance
- Pregnancy RDA
- 770 mcg RAE
- Tolerable upper limit
- 3,000 mcg RAE/day
- Teratogenic window
- First ~60 days
- Safer form
- Beta-carotene
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Vitamin A (Retinol). A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
Pregnancy RDA 770 mcg RAE, UL 3,000 mcg RAE, preformed vitamin A teratogenic above UL, beta-carotene not known to be teratogenic
NIH Office of Dietary Supplements, Vitamin A Fact Sheet for Health Professionals
High supplemental preformed vitamin A associated with cranial neural crest defects; prevalence ratio 4.8 above 10,000 IU/day; ~1 in 57 malformation estimate
EFSA 2024 retains 3,000 mcg RE/day UL for preformed vitamin A on teratogenicity grounds; no UL for beta-carotene; smokers advised to avoid beta-carotene supplements
WHO does not recommend routine vitamin A supplementation in pregnancy; recommends it only where deficiency is a severe public health problem to prevent night blindness
WHO e-Library of Evidence for Nutrition Actions (eLENA), Vitamin A supplementation during pregnancy
WHO 2011 guideline text and rationale for restricting vitamin A supplementation in pregnancy; teratogenicity most sensitive days 15-60 post-conception
WHO Guideline: Vitamin A Supplementation in Pregnant Women (2011), NCBI Bookshelf
Isotretinoin birth defects in 35%+ of exposed pregnancies; ~40% miscarriage in early pregnancy; ear/eye/heart/CNS/jaw/palate malformations; stop ~1 month before conception
MotherToBaby, Isotretinoin (Accutane) Fact Sheet, NCBI Bookshelf
iPLEDGE risk management program requires negative pregnancy tests and two forms of contraception; isotretinoin contraindicated in pregnancy; introduced 1982
Embryo Project Encyclopedia, Isotretinoin (Accutane) as a Teratogen (Arizona State University)
Acitretin (Soriatane) is a known human teratogen contraindicated in pregnancy and for at least 3 years after discontinuation; alcohol prolongs the risk via etretinate
FDA Soriatane (acitretin) prescribing information / boxed warning
High-dose beta-carotene supplements associated with increased lung cancer in smokers (ATBC and CARET trials); dietary beta-carotene not implicated
Vitamin A deficiency is the leading preventable cause of childhood blindness; 250,000-500,000 deficient children go blind yearly, half dying within 12 months; night blindness in pregnancy
WHO, Vitamin A deficiency (Nutrition Landscape Information System)
Isotretinoin-exposed pregnancies persist despite iPLEDGE; real-world program-failure signal
Harvard Gazette reporting on JAMA Dermatology analysis, 2019